Dasan Pharmaceutical Co., Ltd. is a specialized pharmaceutical and bio-company that researches and produces finished pharmaceuticals and active pharmaceutical ingredients based on Drug Delivery System (DDS) and micro-particle coating technology. Based on its KGMP and globally certified production facilities located in Asan, Chungnam, the company conducts Contract Development and Manufacturing Organization (CDMO) services and supplies specialized pharmaceuticals. Recognized for its excellent formulation technology, it maintains broad cooperative relationships with leading domestic and international pharmaceutical companies and continues to show solid growth.

"Adopting the 'Love for People' spirit of Jeong Yak-yong, one of Korea's greatest scholars and scientists, as its founding philosophy, the company is constantly striving for formulation technology research and the production of excellent pharmaceuticals necessary for human health and a happy life. Prioritizing 'Happiness Management and Quality Management,' the company is expanding its support and investment every year to strengthen R&D capabilities to realize the development of well-being pharmaceuticals using DDS technology and to create global No. 1 products."

Business Areas

• Development and Manufacturing of Finished Pharmaceuticals Based on Drug Delivery System (DDS): The company specializes in producing finished pharmaceuticals such as tablets and capsules with improved medication adherence by applying Micro Particle Coating and multi-pelletization technology. It is launching improved new drugs and generics with high-difficulty formulation capabilities that precisely control the drug release pattern in the body.
• Pharmaceutical Contract Development and Manufacturing (CDMO and Contract Manufacturing): Based on its own technology platform and state-of-the-art fluidized bed coating equipment, the company provides contract manufacturing and technology transfer services to domestic and international pharmaceutical companies. It supports customized solutions ranging from R&D, non-clinical/clinical formulation research, product licensing, to commercial production.
• Active Pharmaceutical Ingredients (API) and Herbal Raw Material Supply: Through its own synthesis facilities and an excellent cooperative network, the company develops and supplies high-purity synthetic active pharmaceutical ingredients to domestic and international clients. Based on its MFDS GMP inspection capabilities and exclusive overseas partnerships, it also handles natural products and herbal active pharmaceutical ingredients of stable quality.

Products

• Prostatic Hyperplasia Treatment (Tamsulosin formulations, etc.): These are specialized urological pharmaceuticals applied with sustained-release micro-pellet coating technology, boasting excellent medication adherence. They are core product lines that hold a very high share in the domestic contract manufacturing market and have established technical barriers to entry.
• Chronic Disease Treatments (Hypertension, Cardiovascular, and Central Nervous System drugs): These are finished pharmaceuticals for various disease groups, including antihypertensive agents, digestive system, and central nervous system drugs, incorporating multi-formulation and drug release control technologies. They are manufactured in various forms such as tablets and hard capsules and are supplied to leading large pharmaceutical companies.
• Functional Active Pharmaceutical Ingredients and Herbal Extracts: These are synthetic active pharmaceutical ingredients and high-quality herbal extract raw materials that have passed strict quality standards and DMF approval. They possess high purity and safety that meet the standards of advanced overseas markets such as Japan, as well as domestic standards.

Special Notes

• Differentiated Drug Delivery System (DDS) and Fluidized Bed Coating Core Technology: The company possesses proprietary formulation platforms, including micro-encapsulation manufacturing and N-Nitrosodimethylamine (NDMA) reduction technology. Through this, it holds a unique technical advantage in producing high-difficulty formulations that are difficult for other pharmaceutical companies to imitate.
• Overseas Regulatory Approval and Global-Standard Advanced Production Facilities: The No. 1 and No. 2 plants in Asan, Chungnam, are global-level facilities that have obtained not only KGMP certification but also approval from the Japanese Pharmaceuticals and Medical Devices Agency (MHLW/PMDA). Through state-of-the-art automated coating machines and packaging lines, the company can stably supply large quantities of excellent pharmaceuticals.
• Solid Customer Network and Overwhelming Contract Manufacturing Market Share: The company has secured over 100 major domestic pharmaceutical companies as clients and records a high contract manufacturing market share in major ingredient pharmaceutical markets such as urology. Based on product reliability, it is expanding its market as a global CDMO company.

Recruitment Information

• Main Hiring Positions: Pharmaceutical manufacturing and packaging production staff (operator), Quality Control (QC) and Quality Assurance (QA), Formulation Research and R&D, Facility Management and Maintenance
• Benefits: National pension, health insurance, employment insurance, industrial accident compensation insurance, severance pay, dormitory and commuter bus operation, lunch and meal provision, congratulatory and condolence support and leave, holiday gifts and homecoming expenses, commendation for outstanding employees

💡 A Word from JOBPLOY
Since Dasan Pharmaceutical produces medicines that deal with human life and health, strict hygiene management and compliance with Standard Operating Procedures (SOP) are essential. A meticulous and regular work attitude is required as one must thoroughly follow sterile gown wearing, clean zone management, and established process procedures. Having basic Korean communication skills on-site is advantageous for work adaptation to check the status of production process equipment and convey safety rules.